A Randomized, Double-blind, Parallel-group, Multicentre, Phase III Study to Assess the Effect of Esomeprazole 20 or 40 mg od Versus Placebo on the Occurrence of Peptic Ulcers During 26 Weeks in Subjects on Continuous Low Dose Acetylsalicylic Acid (ASA)
A Randomized, Double-blind, Parallel-group, Multicentre, Phase III Study to Assess the Effect of Esomeprazole 20 or 40 mg od Versus Placebo on the Occurrence of Peptic Ulcers During 26 Weeks in Subjects on Continuous Low Dose Acetylsalicylic Acid (ASA)
The purpose of this study is to compare the effect of esomeprazole 20 or 40 mg once daily versus placebo on the occurrence of peptic ulcers during 26 weeks in subjects on continuous low-dose acetylsalicylic acid.
Inclusion Criteria:
Exclusion Criteria:
Capital Federal, Buenos Aires, Argentina
NSW, Australia
North York, Ontario, Canada
Ostrava - Trebovice, Czechia
Poobram, Czechia
Praha 4 - Sporilov, Czechia
Rodgau-dudenhofen, Germany
D.F, Mexico
Osteros, Norway
Elblog, Poland
Angra Do Herosmo, Portugal
Tg. Mures, Romania
Banska Bysterica, Slovakia
Brastislava, Slovakia